$SIBN

Maheshwari Anshul sold $87K of SIBN

Maheshwari Anshul (Chief Financial Officer) sold 4,665 shares of SI-BONE, Inc. (SIBN) at an average of $18.65 ($18.62–$18.68) across 2 trades on 2026-08-17.

Original reporting
SEC EDGAR · Maheshwari Anshul
Published Aug 18, 2026, 8:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 18, 2026, 9:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SIBN
Neutral
high confidence
Mentioned
$SIBN
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SIBNNeutralLow
01

Why it matters

The disclosure updates the record of insider ownership and may influence short-term sentiment, but it does not provide new company performance or guidance data.

02

Market read

Traders may monitor insider activity for sentiment, but this specific transaction is small and lacks fundamental catalysts.

03

What to watch

Insider sales are often planned for diversification or tax; the filing does not indicate any change in business outlook or risk.

Relevance 3/10Novelty 2/10Timing: filed after-hours on Aug. 18, covering sales on Aug. 17

Background

This is an SEC Form 4 insider transaction for SI-BONE, Inc., reported by the CFO.

Company-level read

Ticker impact

$SIBNNeutralHigh confidence
Context

SI-BONE CFO Maheshwari Anshul sold 4,665 shares in open-market transactions totaling about $87.0K, per Form 4 filed Aug. 18.

Expected impact

Low near-term impact; any effect is likely sentiment-driven and short-lived.

Evidence & confidence

The filing is a Form 4 insider sale, small relative to typical company market caps, and provides no new operational or guidance information.

Market effects

Minimal, as the disclosure is company-specific insider activity without sector-wide signal.

None indicated.

None indicated.

Counterpoint

The absence of a disclosed 10b5-1 plan could be interpreted as discretionary selling, which some traders may read as caution.

Key entities

  • SI-BONE, Inc.

    Company whose CFO reported an open-market sale of shares via SEC Form 4.

  • Maheshwari Anshul

    Chief Financial Officer who sold 4,665 shares across two trades on Aug. 17.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SIBNHigh

SI-BONE, Inc. (SIBN): Results of Operations and Financial Condition

SI-BONE, Inc. (SIBN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance Delivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA ~19% increase in U.S. physician base Second Quarter 2026 Financial Highlights (all comparisons are to t